Recent

% | $
Quotes you view appear here for quick access.

Nordstrom Inc. Message Board

crecy_war_knight 449 posts  |  Last Activity: Jul 31, 2015 2:21 PM Member since: Jan 25, 2007
  • crecy_war_knight by crecy_war_knight Jul 31, 2015 2:21 PM Flag

    not sure if already posted
    http://seekingalpha.com/article/3366275-acadia-pharmaceuticals-developing-late-stage-assets-with-blockbuster-potential?app=1&auth_param=kngo:1arfv08:26108d5878114eba83d6cbaaba09d42b

  • Reply to

    Exel is the next ACAD

    by luxury67897897 Jul 31, 2015 2:14 PM
    crecy_war_knight crecy_war_knight Jul 31, 2015 2:19 PM Flag

    In for a penny ...in for a pound.

  • crecy_war_knight by crecy_war_knight Jul 31, 2015 1:12 PM Flag

    All studies remove patients from data collection when they don't meet the guidelines of the studies. Everyone knows AF is a shill for the shorts. The FDA already went over all the data like last year. And there were no major issues. This article is to help the shorts get out at a lower price. AF is losing his touch anyway. He got beat out of this article buy another admitted short on Twitter. AF you better start doing your homework, stop wasting your time on Twitter or Zach will take your job.

  • Reply to

    like a fool

    by metropath Jul 31, 2015 11:26 AM
    crecy_war_knight crecy_war_knight Jul 31, 2015 12:49 PM Flag

    What you are missing is discipline & focus. What is your strategy (which has a lot to do with how much money you have, income, age, market knowledge, experience etc.) Answer those questions and then and only then should you enter the market. And remember never invest money you can not afford to lose. One of the easiest ways to get into the market is to simply buy mutual funds...eg, the VTI-the total stock market. Or if you really want biotech...buy the IBB- the biotech ETF(there are others). But buy on a sell off day. A RED DAY. Once you have the questions and knowledge, do some "pretend " investments. Get some experience. Read some books. Learn Technical Analysis - Candlesticks, its not perfect, but I find it helps me make buy-sell decisions. Learn how to use the Yahoo charts to learn patterns. Watch Cramer, everyone hates him, but he does explain how big companies do business. He is not good with small biotechs. GL

  • crecy_war_knight crecy_war_knight Jul 31, 2015 12:19 PM Flag

    Excellent point.

  • Every study uses SELECTIVE EXCLUSION when patients don't meet STUDY CRITERIA.

  • crecy_war_knight by crecy_war_knight Jul 31, 2015 11:06 AM Flag

    Patients get excluded from studies all the time. The ITI007 P2 data list 335 randomized, 311 were then included in the study. 24 excluded for several reasons mentioned in the study. I get AF's point - he wanted more details about the exclusion of those 24. These patients were excluded due to invalid baseline measurement, some withdrew from the study prior to getting data. To me this is not unusual, happens all the time in every study. Now I get his point, there was a listing of 8 who were excluded from the 60mg arm , but at some point further on the poster it list 17. So there is something that should be clarified , so maybe someone will ask about it at the Q rept. AF claims 24 patient data is "missing". I am sure the CEO can explain it AGAIN and the short shills will not accept it.

    " The patients did not have a valid baseline measurement of schizophrenia symptoms, or patients withdrew from the study before their schizophrenia symptoms could be measured following their first treatment."

    This poster re-hash on a Friday - to help shorts cover at a lower price. Shorts holding over the weekend can be a tad risky. 24 patients "missing" doesn't seem to have much punch.

  • crecy_war_knight crecy_war_knight Jul 30, 2015 11:15 PM Flag

    IGNORED

  • Reply to

    for you pattern guys...

    by crecy_war_knight Jul 30, 2015 10:45 AM
    crecy_war_knight crecy_war_knight Jul 30, 2015 9:23 PM Flag

    Several and seems like this is fairly typical of this stocks Up trend sequence.

  • Reply to

    Qrpt guess

    by crecy_war_knight Jul 30, 2015 3:52 PM
    crecy_war_knight crecy_war_knight Jul 30, 2015 5:11 PM Flag

    Not sure either now that you mention it, but if it is announced prior (days...hours?) to the Qrept, why not.

  • Reply to

    Qrpt guess

    by crecy_war_knight Jul 30, 2015 3:52 PM
    crecy_war_knight crecy_war_knight Jul 30, 2015 3:58 PM Flag

    M and A announcement is prob less than 1%

  • crecy_war_knight by crecy_war_knight Jul 30, 2015 3:52 PM Flag

    EPS...-xx cents ...CEO search ....possible Davis or Soland will be new CEO....NDA...." On Tract for 2 H "15. That's it. I think no major news reg NDA. .

    Outside chance to annouce ...Ready for submission of NDA....New CEO is Mr/MS...former CEO of a well known Biotech that will take it to approval. ...Partnership with XXX , a huge Biotech. ......

  • Reply to

    Normally dont give much credence

    by artax200222 Jul 30, 2015 11:13 AM
    crecy_war_knight crecy_war_knight Jul 30, 2015 12:42 PM Flag

    Since there is nothing fundamentally wrong, this drop seems like normal cycling , from Over Bought to Over Sold.

  • Reply to

    SOMEBODY PUMP SO I CAN DUMP

    by jrogalav9 Jul 30, 2015 12:30 PM
    crecy_war_knight crecy_war_knight Jul 30, 2015 12:31 PM Flag

    see ya IGNORED

  • Reply to

    ACAD Review

    by crecy_war_knight May 8, 2015 10:09 PM
    crecy_war_knight crecy_war_knight Jul 30, 2015 11:14 AM Flag

    Estimating the number of persons effected by psychosis (= delusions + hallucinations) is difficult due to the "" perceived stigma patients could face so they prefer not to divulge.
    Conservative peak risk-adjusted 2027 pimavanserin PDP revenue estimate by LEERINK (based on 45% share of PD antipsychotic use) is of $1.3B (US excl ROW)

    à Specialists with whom Leerink spoke are optimistic on pimavanserin’s prospects in ADP and more importantly, most plan to use the drug off-label in AD and psychotic dementia once it is approved in PDP, largely due to its relatively cleaner safety profile
    Patent expiry is expected in 2028 so ACAD has 12+ blockbuster patent life.
    Schizophrenia (approval potentially in 2020) and ROW sales are all upside
    Given the scarcity value of a novel CNS drug that is safe and effective, ACAD could be a likely takeout target. CNS companies are full of “me too” depression drugs with generic competition – there is no sector of Big Pharma more in need of acquiring a blockbuster differentiated safe and effective blockbuster with long patent life.
    Recent stumble with NDA delay and CEO departure may make institutions like Baker Brothers and Fidelity more likely to sell even before approval. "" - (This last remark about BB selling I don't agree with-this is an older post. I would be very surprised if after holding this for a long time the BB sell and miss out on huge profits. This must have been written just after the last delay. I believe Pima has about 95% chance of being approved FAST. )

  • crecy_war_knight by crecy_war_knight Jul 30, 2015 10:45 AM Flag

    Bull Flag

  • crecy_war_knight by crecy_war_knight Jul 30, 2015 10:29 AM Flag

    more bad/terrible news that does not drop the stock, then it might be close to the bottom.

  • Reply to

    Is there any worst run Co. than MNKD?

    by crecy_war_knight Jul 29, 2015 11:45 AM
    crecy_war_knight crecy_war_knight Jul 29, 2015 12:10 PM Flag

    Can it be bought out? Hail Mary?

  • Reply to

    Is there any worst run Co. than MNKD?

    by crecy_war_knight Jul 29, 2015 11:45 AM
    crecy_war_knight crecy_war_knight Jul 29, 2015 12:05 PM Flag

    I have been following it about 2 yrs. They have good technology, but very poor execution. The product might get some use, but there are just too many other options for diabetics. Most patients on insulin love their Insulin Pens, brand loyalty. Tiny needles you hardly feel, no refrigeration, I thought it would hit a bottom at 5+, and I would consider buying but Chart is saying $3+. So I wouldn't touch it at this point until I see a change in management. This company has made suckers out of the shareholders. Terrible.

  • Reply to

    It's Time for Adam Fuerstein to Go Away

    by f77sball Jul 29, 2015 9:32 AM
    crecy_war_knight crecy_war_knight Jul 29, 2015 11:52 AM Flag

    AF is just doing what he does best, he puts out his negative articles on vulnerable targets. And MNKD is an easy target. You are mad at the wrong person.

JWN
76.31-0.03(-0.04%)Jul 31 4:04 PMEDT